Pancreatic Cancer Research

ResearcherHarbin Medical UniversityNo recent work listed

Quanxiao Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3866-3868; OpenAlex author ID A5006044998. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 2 papers

Papers 3

  1. Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response and EGFR-Akt pathway modulation. Co-author DOI 10.1038/s41388-020-1260-1↗
  2. Gut Microbiota: Its Potential Roles in Pancreatic Cancer. Co-author DOI 10.3389/fcimb.2020.572492↗
  3. NF-κB in pancreatic cancer: Its key role in chemoresistance. Co-author DOI 10.1016/j.canlet.2018.02.011↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gang Yang · 2 shared papers, 2018–2020 · strength 0.17
  2. Taiping Zhang · 2 shared papers, 2018–2020 · strength 0.17
  3. Yupei Zhao · 2 shared papers, 2018–2020 · strength 0.17
  4. Lei You · 2 shared papers, 2018–2020 · strength 0.17
  5. Limin Jin · 1 shared paper, 2020 · strength 0.16
  6. Yahui Liu · 1 shared paper, 2020 · strength 0.16
  7. Francesca Ricciardiello · 1 shared paper, 2020 · strength 0.10
  8. Fangyu Zhao · 1 shared paper, 2020 · strength 0.10
  9. Jin Gu · 1 shared paper, 2020 · strength 0.10
  10. Ferdinando Chiaradonna · 1 shared paper, 2020 · strength 0.10
  11. Mengyu Feng · 1 shared paper, 2018 · strength 0.08
  12. Jiangdong Qiu · 1 shared paper, 2018 · strength 0.08
  13. Zhe Cao · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.